Skip to content

Analysis of equivalent dose of remazolam and propofol in patients with loss of consciousness under general anesthesia

Analysis of equivalent dose of remazolam and propofol in patients with loss of consciousness under general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067112
Enrollment
Unknown
Registered
2022-12-27
Start date
2023-01-02
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with loss of consciousness under general anesthesia

Interventions

Remazolam 0.1mg/kg:Remazolam 0.1mg/kg
Remazolam 0.15mg/kg:Remazolam 0.15mg/kg
Remazolam 0.2mg/kg:Remazolam 0.2mg/kg
Remazolam 0.25mg/kg:Remazolam 0.25mg/kg
Remazolam 0.3mg/kg:Remazolam 0.3mg/kg
Propofol 1.0mg/kg:Propofol 1.0mg/kg
Propofol 1.5mg/kg:Propofol 1.5mg/kg
Propofol 2.0mg/kg:Propofol 2.0mg/kg
Propofol 2.5mg/kg:Propofol 2.5mg/kg
Propofol 3.0mg/kg:Propofol 3.0mg/kg

Sponsors

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1) American Society of Anesthesiologists (ASA) Grade I-II; (2) Age < 18 years old; (3) Patients undergoing elective surgery requiring general anesthesia; (4) No history of systemic disease (5) Get permission from parents or guardians (sign informed consent form)

Exclusion criteria

Exclusion criteria: (1) Patients undergoing hepatectomy or liver transplantation; (2) Abnormal liver function and history of other systemic diseases; (3) Patients with liver disease (liver disease history, bilirubin =3.0 mg/dl, or aspartic aminotransferase/alanine aminotransferase =2.5 times the upper limit of normal); (4) patients with nephropathy (serum creatinine =2 mg/dl); (5) Intolerance or allergy to benzodiazepines; (6) History of drug addiction; (7) Children who planned to undergo local anesthesia before anesthesia induction

Design outcomes

Primary

MeasureTime frame
Time of loss of consciousness;

Countries

CHINA

Contacts

Public ContactYang Shen

Shanghai Children’s Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine

rdshenyang@163.com+86 18201806327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026